UCLA scientists first to track joint cartilage development in humans

Stem cell researchers from UCLA’s Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have published the first study to identify the origin cells and track the early development of human articular cartilage, providing what could be a new cell source and biological roadmap for therapies to repair cartilage defects and osteoarthritis. These revolutionary therapies could reach clinical trials within three years.

Transforming Medicine: An Evening with UCLA Stem Cell Scientists

 An Evening with UCLA Stem Cell Scientists"

Tuesday | October 22, 2013

6.30PM - 8.30PM
Ronald Reagan Medical Center
Tamkin Auditorium (B-130)
757 Westwood Plaza

Four prominent UCLA stem cell researchers receive CIRM early translational grants

Four prominent researchers from UCLA’s Eli & Edythe Broad Center of Regenerative Medicine and Stem Cell Research have received Early Translational research awards totaling approximately $13 million from the California Institute for Regenerative Medicine (CIRM) the state stem cell agency. The UCLA researchers received four of the 12 total awards; no other applicant institution received more than one award.

Researcher wins prestigious McCullough and Till Award

Dr. Hanna Mikkola

Dr. Hanna Mikkola, member of the UCLA Eli & Edythe Broad Center for Regenerative Medicine & Stem Cell Research and the Jonsson Comprehensive Cancer Center, and an associate professor of molecular, cell, and developmental biology in the life sciences has been named the 2013 recipient of the McCulloch and Till Award by the Society for Hematology and Stem Cells, also known as the ISEH.

UCLA Broad Stem Cell Research Center gene therapy for sickle cell disease advances toward clinical trials

Researchers at UCLA’s Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research have successfully established the foundation for using hematopoietic (blood-producing) stem cells (HSC) from the bone marrow of patients with sickle cell disease (SCD) to treat the disease. The study was led by Dr. Donald Kohn, professor of pediatrics and microbiology, immunology and molecular genetics in the life sciences.

UCLA stem cell researchers move toward treatments for rare genetic nerve disease

UCLA researchers develop new method for purifying stem cells for treatment

UCLA Scientist Wins CIRM's Elevator Speech Challenge

UCLA stem cell researcher receives CIRM grant as part of stem cell “bank” initiative

UCLA researchers monitor T cell function to improve melanoma treatment

Pages